Get started Log in

SENZA — SenzaGen AB Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
SEK182.04m
Enterprise Value
SEK161.77m
Revenue
SEK57.97m

Brief: SenzaGen Signs Distribution Agreement In France
17/12/2019 09:04
Brief: SenzaGen Signs Agreement With VitroScreen In Italy
11/12/2019 07:37
Brief: SenzaGen Gets About SEK 42.4 Mln Through Rights Issue
10/12/2019 14:37
Brief: SenzaGen Gets About SEK 64 Mln In Directed Issue
12/11/2019 10:53
Brief: SenzaGen Sets New Target To Reach Break-Even In 2022
19/09/2019 07:17
Brief: Senzagen Expands Its Product Portfolio With Test For The Medical Devices Market
27/08/2019 07:33
Brief: SenzaGen H1 Operating Loss Widens To SEK 15.2 Million
22/08/2019 07:41
Brief: SenzaGen Gets Patent In Europe
13/06/2019 10:19
Brief: SenzaGen Receives New Order Of SEK 0.5 Mln
17/05/2019 07:34
Brief: Senzagen Appoints Axel Sjöblad New CEO
12/04/2019 07:34
Brief: SenzaGen Increases Its Presence In US Via License Agreement With MB Research Labs
07/03/2019 07:37
Brief: Senzagen Granted Additional Patent In Asia
06/03/2019 12:49
Brief: Senzagen H2 Operating Loss Widens To SEK 12.3 Million
14/02/2019 07:38
Brief: Senzagen Aims At Reaching Break-Even In 2021
09/10/2018 07:31
Brief: Senzagen Signs Cooperation Agreement With Research Institutes Of Sweden
29/08/2018 07:49
Brief: Senzagen H1 Loss Widens To SEK 8.5 Million
22/08/2018 07:48
Brief: SenzaGen Says Results From Study Show GARDskin™ Could Be Established As First Animal-Free Standalone Test
31/07/2018 07:52
Brief: SenzaGen Signs Distribution Agreement With French Test Laboratory Eurosafe
16/07/2018 07:51
Brief: Senzagen Receives Patent Protection For Gardskin™ In China
11/07/2018 07:51
Brief: Senzagen Signs License Agreement In USA
07/03/2018 09:04